Squarepoint’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,299
| Closed | -$99.1K | – | 2986 |
|
|
2025
Q1 | $99.1K | Buy |
+20,299
| New | +$99.1K | ﹤0.01% | 2526 |
|
|
2024
Q4 | – | Sell |
-9,850
| Closed | -$76.2K | – | 3030 |
|
|
2024
Q3 | $76.2K | Buy |
9,850
+5,766
| +141% | +$44.6K | ﹤0.01% | 2388 |
|
|
2024
Q2 | $24.5K | Buy |
+4,084
| New | +$24.5K | ﹤0.01% | 2409 |
|
|
2024
Q1 | – | Sell |
-18,671
| Closed | -$177K | – | 2690 |
|
|
2023
Q4 | $177K | Buy |
18,671
+3,378
| +22% | +$32K | ﹤0.01% | 2174 |
|
|
2023
Q3 | $182K | Buy |
+15,293
| New | +$182K | ﹤0.01% | 2144 |
|
|
2023
Q2 | – | Sell |
-29,538
| Closed | -$925K | – | 2633 |
|
|
2023
Q1 | $925K | Buy |
+29,538
| New | +$925K | ﹤0.01% | 1211 |
|
|
2022
Q3 | – | Sell |
-3,901
| Closed | -$323K | – | 2301 |
|
|
2022
Q2 | $323K | Buy |
3,901
+2,546
| +188% | +$211K | ﹤0.01% | 1556 |
|
|
2022
Q1 | $225K | Sell |
1,355
-3,479
| -72% | -$578K | ﹤0.01% | 1861 |
|
|
2021
Q4 | $808K | Buy |
+4,834
| New | +$808K | ﹤0.01% | 1329 |
|
|
2020
Q2 | – | Sell |
-3,623
| Closed | -$158K | – | 2309 |
|
|
2020
Q1 | $158K | Buy |
+3,623
| New | +$158K | ﹤0.01% | 1541 |
|